comparitive study of caudal clonidine versus dexmedetomidine for post operative analgesia in paediatric patients

COMPARITIVE STUDY OF CAUDAL CLONIDINE WITH ROPIVACAINE VERSUS DEXMEDETOMIDINE WITH ROPIVACAINE FOR POST OPERATIVE ANALGESIA IN PEADIATRIC PATIENTS - COMPARITIVE STUDY OF CAUDAL CLONIDINE VERSUS DEXMEDETOMIDINE

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/12/022479

Enrollment

Registered

2019-12-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: ropivacaine 0.25 % 1 ml/kg: caudal block Control Intervention1: dexmedetomidine 1mcg/kg: caudal block Control Intervention2: clonidine 1mcg/kg: caudal block

Eligibility

Inclusion criteria

Inclusion criteria: 1.asa grade 1 and 2 2.children between 2 to 6 age group 3.elective below umblical surgeries

Exclusion criteria

Exclusion criteria: 1.children with local infection at the caudal region 2.coagulopathy 3.pre existing neurological or obvious spinal diseases 4.history of developmental delay and congenital anomaly 5.known allergy to study drug 6.refusal of parents

Design outcomes

Primary

Measure	Time frame
duration of post operative analgesiaTimepoint: 0,1,2,4,6,8,10,12,16,20,24 hours	—

Secondary

Measure	Time frame
incidence of complicationsTimepoint: 1,2,3,4,8,16,24 hours	—

Countries

India

Contacts

Public ContactR PAUL RAFSON JANI

MGM ECHRS

pramod.bhale@gmail.com8888819021

Outcome results